- Home
- PHVS vs AMSC Comparison
PHVS vs AMSC Comparison
Compare PHVS & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHVS | AMSC |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2021 | 1991 |
Fundamental Metrics
Financial Performance| Metric | PHVS | AMSC |
|---|---|---|
| Price | $25.46 | $30.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $39.44 | ★ $45.50 |
| AVG Volume (30 Days) | 505.6K | ★ 781.7K |
| Earning Date | 11-12-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $266,277,000.00 |
| Revenue This Year | N/A | $31.57 |
| Revenue Next Year | N/A | $21.46 |
| P/E Ratio | ★ N/A | $83.21 |
| Revenue Growth | N/A | ★ 51.17 |
| 52 Week Low | $11.51 | $13.98 |
| 52 Week High | $29.80 | $70.49 |
Technical Indicators
Market Signals| Indicator | PHVS | AMSC |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 38.52 |
| Support Level | $25.00 | $28.97 |
| Resistance Level | $27.45 | $32.29 |
| Average True Range (ATR) | 1.34 | 1.44 |
| MACD | 0.03 | 0.66 |
| Stochastic Oscillator | 55.35 | 33.84 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.